FindTrial
Sign In

The diagnosis and prognosis value of ST2 and galectin-3 on early acute ST segment elevation myocardial infarction

The diagnosis and prognosis value of ST2 and galectin-3 on early acute ST segment elevation myocardial infarction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RDC-17013848
Enrollment
Unknown
Registered
2017-12-11
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ST segment elevation myocardial infarction

Interventions

Case series:Nil

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. ST-segment elevation myocardial infarction; 2. coronary angiography.

Exclusion criteria

Exclusion criteria: prior PCI or CABG

Design outcomes

Primary

MeasureTime frame
Galectin 3;ST2;—

Countries

China

Contacts

Public ContactYe Xuying

Tianjin First Central Hospital

l-long@163.com+86

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026